SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001217
Filing Date
2023-05-15
Accepted
2023-05-15 16:08:46
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrkr-20230331x10q.htm   iXBRL 10-Q 1052407
2 EX-10.1 mrkr-20230331xex10d1.htm EX-10.1 56557
3 EX-10.2 mrkr-20230331xex10d2.htm EX-10.2 144401
4 EX-31.1 mrkr-20230331xex31d1.htm EX-31.1 15009
5 EX-31.2 mrkr-20230331xex31d2.htm EX-31.2 14908
6 EX-32.1 mrkr-20230331xex32d1.htm EX-32.1 6663
7 EX-32.2 mrkr-20230331xex32d2.htm EX-32.2 6755
8 GRAPHIC mrkr-20230331x10q001.jpg GRAPHIC 9834
9 GRAPHIC mrkr-20230331x10q002.jpg GRAPHIC 51317
  Complete submission text file 0001410578-23-001217.txt   5350572

Data Files

Seq Description Document Type Size
10 EX-101.SCH mrkr-20230331.xsd EX-101.SCH 46346
11 EX-101.CAL mrkr-20230331_cal.xml EX-101.CAL 37801
12 EX-101.DEF mrkr-20230331_def.xml EX-101.DEF 161333
13 EX-101.LAB mrkr-20230331_lab.xml EX-101.LAB 363135
14 EX-101.PRE mrkr-20230331_pre.xml EX-101.PRE 280301
67 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20230331x10q_htm.xml XML 703757
Mailing Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032
Business Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 23922221
SIC: 2834 Pharmaceutical Preparations